• SPX
  • $5,751.07
  • 0.9 %
  • $51.13
  • DJI
  • $42,352.75
  • 0.81 %
  • $341.16
  • N225
  • $38,635.62
  • 0.22 %
  • $83.56
  • FTSE
  • $8,280.63
  • -0.02 %
  • -$1.89
  • IXIC
  • $18,137.85
  • 1.22 %
  • $219.38
Avenue Therapeutics, Inc. (ATXI) Competitors

Avenue Therapeutics, Inc. (ATXI) Competitors

NASDAQ Currency in USD Disclaimer

Stock Price

$2.08

-$0.24

(-10.2%)

Day's range
$2.07
Day's range
$2.4

Avenue Therapeutics, Inc. Competitors

Symbol Company Share Price Market Cap P/E Ratio Employee Count Revenue
ALLR
Allarity Therapeutics, Inc. $1.75 $8.82 M 0 5 $0
BDRX
Biodexa Pharmaceuticals Plc $5.47 $222,107 -0.09 21 $381,000
CFRX
ContraFect Corporation $0.23 $371,901 -0 23 $0
CNSP
CNS Pharmaceuticals, Inc. $0.12 $1.20 M -0.01 3 $0
HOTH
Hoth Therapeutics, Inc. $0.80 $5.33 M -0.58 2 $0
KRBP
Kiromic BioPharma, Inc. $1.03 $4.24 M -0.37 35 $0
NRBO
NeuroBo Pharmaceuticals, Inc. $2.71 $19.28 M 13.1 8 $7,000
PALI
Palisade Bio, Inc. $3.44 $4.28 M -0.19 9 $250,000
PBLA
Panbela Therapeutics, Inc. $0.35 $1.80 M 0.01 7 $0
QNRX
Quoin Pharmaceuticals, Ltd. $0.48 $2.73 M -0.11 4 $0
REVB
Revelation Biosciences, Inc. $0.82 $3.59 M -0.05 9 $0
VRAX
Virax Biolabs Group Limited $1.94 $4.65 M -0.11 17 $156,419
WINT
Windtree Therapeutics, Inc. $1.12 $1.88 M 0.24 20 $0
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.